2d55: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older edit
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
 
(8 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Seed}}
[[Image:2d55.png|left|200px]]


<!--
==Structural, physical and biological characteristics of RNA.DNA binding agent N8-actinomycin D==
The line below this paragraph, containing "STRUCTURE_2d55", creates the "Structure Box" on the page.
<StructureSection load='2d55' size='340' side='right'caption='[[2d55]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
You may change the PDB parameter (which sets the PDB file loaded into the applet)
== Structural highlights ==
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
<table><tr><td colspan='2'>[[2d55]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptomyces_antibioticus Streptomyces antibioticus]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=1d55 1d55]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2D55 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2D55 FirstGlance]. <br>
or leave the SCENE parameter empty for the default display.
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3&#8491;</td></tr>
-->
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DVA:D-VALINE'>DVA</scene>, <scene name='pdbligand=MVA:N-METHYLVALINE'>MVA</scene>, <scene name='pdbligand=PXZ:2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL-10-DEHYDRO-PHENOXAZIN-3-ONE'>PXZ</scene>, <scene name='pdbligand=SAR:SARCOSINE'>SAR</scene></td></tr>
{{STRUCTURE_2d55|  PDB=2d55  |  SCENE=  }}
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2d55 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2d55 OCA], [https://pdbe.org/2d55 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2d55 RCSB], [https://www.ebi.ac.uk/pdbsum/2d55 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2d55 ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The crystal structures of the 2:1 complex of the self-complementary DNA octamer d(GAAGCTTC) with actinomycin D has been determined at 3.0 A resolution. This is the first example of a crystal structure of a DNA-drug complex in which the drug intercalates into the middle of a relatively long DNA segment. The results finally confirmed the DNA-actinomycin intercalation model proposed by Sobell &amp; co-workers in 1971. The DNA molecule adopts a severely distorted and slightly kinked B-DNA-like structure with an actinomycin D molecule intercalated in the middle sequence, GC. The two cyclic depsipeptides, which differ from each other in overall conformation, lie in the minor groove. The complex is further stabilized by forming base-peptide and chromophore-backbone hydrogen bonds. The DNA helix appears to be unwound by rotating one of the base-pairs at the intercalation site. This single base-pair unwinding motion generates a unique asymmetrically wound helix at the binding site of the drug, i.e. the helix is loosened at one end of the intercalation site and tightened at the other end. The large unwinding of the DNA by the drug intercalation is absorbed mostly in a few residues adjacent to the intercalation site. The asymmetrical twist of the DNA helix, the overall conformation of the two cyclic depsipeptides and their interaction mode with DNA are correlated to each other and rationally explained.


===STRUCTURAL, PHYSICAL AND BIOLOGICAL CHARACTERISTICS OF RNA.DNA BINDING AGENT N8-ACTINOMYCIN D===
Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D.,Kamitori S, Takusagawa F J Mol Biol. 1992 May 20;225(2):445-56. PMID:1593629<ref>PMID:1593629</ref>


 
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
<!--
</div>
The line below this paragraph, {{ABSTRACT_PUBMED_7541244}}, adds the Publication Abstract to the page
<div class="pdbe-citations 2d55" style="background-color:#fffaf0;"></div>
(as it appears on PubMed at http://www.pubmed.gov), where 7541244 is the PubMed ID number.
== References ==
-->
<references/>
{{ABSTRACT_PUBMED_7541244}}
__TOC__
 
</StructureSection>
==About this Structure==
[[Category: Large Structures]]
This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=1d55 1d55]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2D55 OCA].
[[Category: Streptomyces antibioticus]]
 
[[Category: Carlson RG]]
==Reference==
[[Category: Chu W]]
Structural, physical, and biological characteristics of RNA.DNA binding agent N8-actinomycin D., Shinomiya M, Chu W, Carlson RG, Weaver RF, Takusagawa F, Biochemistry. 1995 Jul 4;34(26):8481-91. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/7541244 7541244]
[[Category: Shinomiya M]]
[[Category: Carlson, R G.]]
[[Category: Takusagawa F]]
[[Category: Chu, W.]]
[[Category: Weaver RF]]
[[Category: Shinomiya, M.]]
[[Category: Takusagawa, F.]]
[[Category: Weaver, R F.]]
[[Category: Complexed with drug]]
[[Category: Double helix]]
[[Category: Right handed dna]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 17:14:49 2008''
Retrieved from "https://proteopedia.org/2d55"